Top Biotechs at ASCO: Ruthie Davi on AI and Data Insights in Platinum-Resistant Ovarian Cancer

News
For life sciences professionals interested in oncology research and the latest cutting-edge cancer therapies, #ASCO25 was not to be missed! I was blown away by the outstanding work being done to deepen our understanding of the disease, and bring innovative new treatments to market.
Thank you to @OncoDaily for featuring my highlights in their “Top Biotechs at ASCO 2025” video series. I was proud to explore our partnership with AbbVie to assess ovarian cancer treatments, and how our new, AI-powered Protocol Optimization is revolutionizing our partners’ approach to clinical trial design.
Check out the full video: